Fem Tech World explores the latest developments in fem tech investments. PinkDx completes Series A Financing PinkDx has completed a second close of its Series A...
Females have a 31 per cent higher associated risk of developing Long Covid, with women aged 40 to 55 years having the highest propensity, according to...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase 2 clinical trial....
Almost half of women across the globe say that healthcare companies are not meeting their needs, highlighting a multimillion dollar opportunity in female-focused healthcare products. A...
There has been a “shocking” decline in testing for cancer in women across the globe, a new report has revealed. Only 10 per cent of women...
Corporate chain ownership of fertility clinics not only increases access to treatment but also enhances patient outcomes, a new study shows. The study shows that chain-owned...
Telephone-delivered acceptance and commitment therapy (ACT) is beneficial for reducing fatigue’s interference with functioning and improves the quality of life for survivors of metastatic breast cancer,...
Europe’s first private, women’s health tissue bank has been launched by Liverpool-based laboratory and medical education provider BioGrad, backed by a £25m investment. The new tissue...
FemTech medical device company Zero Candida Technologies has listed on the Frankfurt Stock Exchange (FSE) under the trading symbol “9L2”. The listing expands Zero Candida’s global...
A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated...
